ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

The Cancer Letter Wins Journalism Award

April 1, 2011

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999